These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
301 related articles for article (PubMed ID: 27495048)
1. A meta-analysis for efficacy and safety evaluation of transcatheter left atrial appendage occlusion in patients with nonvalvular atrial fibrillation. Wei Z; Zhang X; Wu H; Xie J; Dai Q; Wang L; Xu B Medicine (Baltimore); 2016 Aug; 95(31):e4382. PubMed ID: 27495048 [TBL] [Abstract][Full Text] [Related]
2. Efficacy and safety of catheter ablation combined with left atrial appendage occlusion for nonvalvular atrial fibrillation: A systematic review and meta-analysis. Jiang Y; Li F; Li D; Cheng Y; Jia Y; Fu H; Pu X; Hu H; Jiang J; Zeng R Pacing Clin Electrophysiol; 2020 Jan; 43(1):123-132. PubMed ID: 31721242 [TBL] [Abstract][Full Text] [Related]
3. Percutaneous left atrial appendage occlusion for stroke prophylaxis in nonvalvular atrial fibrillation: a systematic review and analysis of observational studies. Bajaj NS; Parashar A; Agarwal S; Sodhi N; Poddar KL; Garg A; Tuzcu EM; Kapadia SR JACC Cardiovasc Interv; 2014 Mar; 7(3):296-304. PubMed ID: 24650403 [TBL] [Abstract][Full Text] [Related]
4. Safety and efficacy of percutaneous Watchman 2.5 device versus Amplatzer Amulet for left atrial appendage closure in patients with non-valvular atrial fibrillation: A systematic review and study-level meta-analysis. Yasmin F; Ali E; Moeed A; Zaidi F; Umar M; Virwani V PLoS One; 2024; 19(2):e0295804. PubMed ID: 38354181 [TBL] [Abstract][Full Text] [Related]
5. Residual flow may increase the risk of adverse events in patients received combined catheter ablation and transcatheter left atrial appendage closure for nonvalvular atrial fibrillation: a meta-analysis. Han Z; Wu X; Chen Z; Ji W; Liu X; Liu Y; Di W; Li X; Yu H; Zhang X; Xu B; Lan RF; Xu W BMC Cardiovasc Disord; 2019 Jun; 19(1):138. PubMed ID: 31182014 [TBL] [Abstract][Full Text] [Related]
6. PLAATO (Percutaneous Left Atrial Appendage Transcatheter Occlusion) for prevention of cardioembolic stroke in non-anticoagulation eligible atrial fibrillation patients: results from the European PLAATO study. Bayard YL; Omran H; Neuzil P; Thuesen L; Pichler M; Rowland E; Ramondo A; Ruzyllo W; Budts W; Montalescot G; Brugada P; Serruys PW; Vahanian A; Piéchaud JF; Bartorelli A; Marco J; Probst P; Kuck KH; Ostermayer SH; Büscheck F; Fischer E; Leetz M; Sievert H EuroIntervention; 2010 Jun; 6(2):220-6. PubMed ID: 20562072 [TBL] [Abstract][Full Text] [Related]
7. Early results of first versus second generation Amplatzer occluders for left atrial appendage closure in patients with atrial fibrillation. Gloekler S; Shakir S; Doblies J; Khattab AA; Praz F; Guerios Ê; Koermendy D; Stortecky S; Pilgrim T; Buellesfeld L; Wenaweser P; Windecker S; Moschovitis A; Jaguszewski M; Landmesser U; Nietlispach F; Meier B Clin Res Cardiol; 2015 Aug; 104(8):656-65. PubMed ID: 25736061 [TBL] [Abstract][Full Text] [Related]
8. Prospective randomized evaluation of the Watchman Left Atrial Appendage Closure device in patients with atrial fibrillation versus long-term warfarin therapy: the PREVAIL trial. Holmes DR; Kar S; Price MJ; Whisenant B; Sievert H; Doshi SK; Huber K; Reddy VY J Am Coll Cardiol; 2014 Jul; 64(1):1-12. PubMed ID: 24998121 [TBL] [Abstract][Full Text] [Related]
9. Device-Related Thrombosis After Percutaneous Left Atrial Appendage Occlusion for Atrial Fibrillation. Fauchier L; Cinaud A; Brigadeau F; Lepillier A; Pierre B; Abbey S; Fatemi M; Franceschi F; Guedeney P; Jacon P; Paziaud O; Venier S; Deharo JC; Gras D; Klug D; Mansourati J; Montalescot G; Piot O; Defaye P J Am Coll Cardiol; 2018 Apr; 71(14):1528-1536. PubMed ID: 29622159 [TBL] [Abstract][Full Text] [Related]
10. Efficacy and Safety of Percutaneous Left Atrial Appendage Occlusion for Stroke Prevention in Nonvalvular Atrial Fibrillation: A Meta-analysis of Contemporary Studies. Xu H; Xie X; Wang B; Ma S; Wang F Heart Lung Circ; 2016 Nov; 25(11):1107-1117. PubMed ID: 27199213 [TBL] [Abstract][Full Text] [Related]
11. Feasibility of Left Atrial Appendage Occlusion for Left Atrial Appendage Thrombus in Patients With Persistent Atrial Fibrillation. Lee OH; Kim JS; Pak HN; Hong GR; Shim CY; Uhm JS; Cho IJ; Joung B; Yu CW; Lee HJ; Kang WC; Shin ES; Choi RK; Lim DS; Jang Y Am J Cardiol; 2018 Jun; 121(12):1534-1539. PubMed ID: 29631803 [TBL] [Abstract][Full Text] [Related]
12. Comparison between Amplatzer and Watchman Left Atrial Appendage Closure Devices for Stroke Prevention in Atrial Fibrillation: A Systematic Review and Meta-Analysis. Qiao J; Zhang B; Wang J; Pan L; Cheng T; Wang Y; Xiong E Cardiology; 2022; 147(3):290-297. PubMed ID: 35468598 [TBL] [Abstract][Full Text] [Related]
13. Long-Term Safety and Efficacy in Continued Access Left Atrial Appendage Closure Registries. Holmes DR; Reddy VY; Gordon NT; Delurgio D; Doshi SK; Desai AJ; Stone JE; Kar S J Am Coll Cardiol; 2019 Dec; 74(23):2878-2889. PubMed ID: 31806131 [TBL] [Abstract][Full Text] [Related]
14. Percutaneous left atrial appendage occlusion for patients in atrial fibrillation suboptimal for warfarin therapy: 5-year results of the PLAATO (Percutaneous Left Atrial Appendage Transcatheter Occlusion) Study. Block PC; Burstein S; Casale PN; Kramer PH; Teirstein P; Williams DO; Reisman M JACC Cardiovasc Interv; 2009 Jul; 2(7):594-600. PubMed ID: 19628179 [TBL] [Abstract][Full Text] [Related]
15. Clinical Results of Left Atrial Appendage Closure with Watchman Device in Patients with Atrial Fibrillation. Pheerawong P; Songmuang SB; Lertsuwunseri V; Satitthummanid S; Srimahachota S J Med Assoc Thai; 2015 Oct; 98(10):942-9. PubMed ID: 26638585 [TBL] [Abstract][Full Text] [Related]
16. 5-Year Outcomes After Left Atrial Appendage Closure: From the PREVAIL and PROTECT AF Trials. Reddy VY; Doshi SK; Kar S; Gibson DN; Price MJ; Huber K; Horton RP; Buchbinder M; Neuzil P; Gordon NT; Holmes DR; J Am Coll Cardiol; 2017 Dec; 70(24):2964-2975. PubMed ID: 29103847 [TBL] [Abstract][Full Text] [Related]
17. Clinical efficacy and safety comparison of Watchman device versus ACP/Amulet device for percutaneous left atrial appendage closure in patients with nonvalvular atrial fibrillation: A study-level meta-analysis of clinical trials. Bing S; Chen RR Clin Cardiol; 2023 Feb; 46(2):117-125. PubMed ID: 36448417 [TBL] [Abstract][Full Text] [Related]
18. Left atrial appendage exclusion for stroke prevention in patients with nonrheumatic atrial fibrillation. Onalan O; Crystal E Stroke; 2007 Feb; 38(2 Suppl):624-30. PubMed ID: 17261703 [TBL] [Abstract][Full Text] [Related]
19. Left Atrial Appendage Occlusion Device and Novel Oral Anticoagulants Versus Warfarin for Stroke Prevention in Nonvalvular Atrial Fibrillation: Systematic Review and Meta-Analysis of Randomized Controlled Trials. Briceno DF; Villablanca P; Cyrille N; Massera D; Bader E; Manheimer E; Aagaard P; Ferrick K; Gross J; Kim SG; Krumerman A; Palma E; Guttenplan N; Romero J; Fisher J; Garcia M; Natale A; Di Biase L Circ Arrhythm Electrophysiol; 2015 Oct; 8(5):1057-64. PubMed ID: 26226997 [TBL] [Abstract][Full Text] [Related]
20. Left atrial appendage closure followed by 6 weeks of antithrombotic therapy: a prospective single-center experience. Chun KR; Bordignon S; Urban V; Perrotta L; Dugo D; Fürnkranz A; Nowak B; Schmidt B Heart Rhythm; 2013 Dec; 10(12):1792-9. PubMed ID: 23973952 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]